RT - Journal
TY - JOUR
A1 - Kakati, Kaberi
A1 - Rahman, Tashnin
A1 - Barman, Debabrata
A1 - Bhattacharyya, Mouchumee
A1 - Borthakur, Bibhuti
A1 - Barman, Rashmisnata
A1 - Kalita, Apurba
A1 - Kataki, Amal
A1 - Krishnatreya, Manigreeva
T1 - Mortality audit of 19 patients with cancer and SARS-CoV-2 positivity
YR - 2022/1/1
JF - Journal of Current Oncology
JO - J Curr Oncol
SP - 21
OP - 24
VO - 5
IS - 1
UL - http://www.https://journalofcurrentoncology.org//article.asp?issn=2589-8892;year=2022;volume=5;issue=1;spage=21;epage=24;aulast=Kakati;t=5
DO - 10.4103/jco.jco_3_22
N2 - Introduction: Coronavirus disease-2019 (COVID-19) has disrupted cancer care services globally. The main objective of this study was to review the cause of deaths in admitted patients with cancer with positive report for severe acute respiratory syndrome coronavirus – 2 (SARS-CoV-2). Materials and Methods: The present review of the cause of deaths was conducted in a tertiary care cancer center in the North East India. In our institute, all cancer patients requiring admission for surgery, chemotherapy, and other daycare procedures require testing for SARS-CoV-2. Results: From 9 July 2020 to 16 May 2021, 119 cancer patients with SARS-CoV-2 positive report or COVID-19 have been admitted to our institute COVID ward. A total of 19 cancer patients with COVID-19 succumbed. Of 19 deaths, 13 (68.4%) patients were men and 6 (31.6%) patients were women. The age range was from 27 years to 74 years (median =55 years). Vomiting alone or with diarrhea was the most common symptom requiring admission after testing (4/19, 21.0%), followed by bleeding from the primary tumor site (3/19, 15.7%). Conclusion: The antecedent and underlying cause of deaths in 19 (100%) patients was cancer. SARS-CoV-2 infection should not be a hindrance to cancer treatment and management.
ER -